IGF2 and systemic sclerosis: Despite higher steady-state levels of TGFβ1 gene expression in IPF and SSc compared to NL fibroblasts, IGF-II stimulation led to modestly decreased TGFβ1 transcript levels over time in these fibroblast populations (Fig 5B).